Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

David Beeson, Professor in Molecular Neurosciences, and Robert MacLaren, Professor of Ophthalmology, have been elected Fellows of the Academy of Medical Sciences.

Professor Beeson has made an exceptional contribution to the study of neuromuscular disorders where the communication between nerve cells and muscle is impaired. His most recent research has focused on translating molecular knowledge of neuromuscular synapse biology into treatment for inherited (congenital) myasthenic syndromes (CMS). Recent work with patients has led to prospective clinical studies showing the dramatic beneficial effects of β2-adrenergic receptor in treating many forms of CMS.

Professor MacLaren  pioneers new treatments for blindness, particularly in patients with incurable retinal diseases, using stem cell-based approaches, gene therapy or electronic retinas. His laboratory is also developing new techniques for cataract and retinal surgery. Together with the University of Oxford in 2014 he co-founded Nightstar, a biotechnology company based at the Wellcome Trust in London, to develop gene therapy treatments for patients with retinal diseases.

Fellowship of the Academy is based on exceptional contributions to the medical sciences, either in the form of original discovery or of sustained contributions to scholarship. Fellows are drawn primarily from biomedical science and academic medicine, but also from veterinary science, dentistry, laboratory science, medical and nursing care and other professions allied to medical science. 

In all a total of seven Oxford researchers were elected this year.

Similar stories

Highly Cited Researchers 2021

Our researchers feature strongly in the latest list

Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize

In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.

Alexander Davies wins top UKRI Future Leaders Fellowship

Alex is one of eight Oxford University academics who have been awarded significant financial funding from the UKRI Future Leaders Fellowships Scheme

Lecture Theatre renamed to honour Sir Colin Blakemore FRS

The Large Lecture Theatre in the Sherrington Building is being renamed the Blakemore Lecture Theatre in tribute to the longest serving Waynflete Professor of Physiology Sir Colin Blakemore FRS following a prestigious Festschrift event held in Professor Blakemore's honour.

The prime of Professor Dame Kay Davies

Professor Dame Kay Davies, Professor of Genetics, first woman appointed Dr Lee's Professor of Anatomy at Oxford, first woman to become Head of Department for DPAG, University-wide champion of equality, and award winning scientist known for her work on Duchenne muscular dystrophy, has 'retired' after a lifetime's research, but remains Professor Emeritus at DPAG.

Professor Christopher Fairburn Awarded OBE for Services to the Treatment of Eating Disorders

Christopher Fairburn founded the Centre for Research on Eating Disorders (CREDO) at Oxford in 1986 and has continued pioneering work into the treatment of eating disorders.